ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook.
I keep hitting the buy button on SoFi Technologies (NASDAQ:SOFI | SOFI Price Prediction), and the Fed-driven tech sell-off this month has only made my finger heavier.
The Norwegian defense group aims to more than quadruple its revenue in the coming years, buoyed by the development of new products and the continued rise in global military spending.
Novel lead small molecules demonstrate substantial reduction of cholesterol accumulation in NPC patient-derived fibroblasts, with additional data supporting lysosomal health and cellular signaling
Sociedad Química y Minera de Chile posted mixed Q1 results, with revenues beating estimates, while revenues were a sizable miss. The bigger story is the dramatic Y-O-Y rise in revenues and earnings,
Starz Entertainment remains a compelling "Buy," with strong tailwinds and an attractive valuation despite doubling YTD. Exiting the unprofitable Universal Pay Two deal accelerates STRZ's path to a 20%
United Parks & Resorts Inc. (NYSE:PRKS) reported Monday first-quarter 2026 results that missed analyst estimates on revenue and earnings as unfavorable weather and weaker international visitation pres
Virtuix NASDAQ: VTIX executives outlined the company's consumer, enterprise and defense strategy during an investor webinar, while also addressing recent volatility in the company's share price.
The SOX continues to follow its projected historical returns and Elliott Wave path, but the advance may be nearing exhaustion, raising the probability of a retracement toward $10,000.
The AI chip maker has a storied relationship with the $200 mark. They haven't always got on.
The increasingly lofty premium Navitas has garnered since announcing the collaboration with Nvidia on 800V HVDCs underscores a valuation that's gone too far, too fast. Just the past week, Navitas Semi
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces the release of its annual
Sharp Corp. (OTCMKTS:SHCAY - Get Free Report) was the recipient of a significant drop in short interest in March. As of March 31st, there was short interest totaling 6,455 shares, a drop of 57.2% from
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term
Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has cl
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE